Philippines Dialysis Market Report and Forecast 2024-2032

Philippines Dialysis Market Outlook

The Philippines dialysis market size is expected to grow at a CAGR of 5.2% during the forecast period of 2024-2032, driven by the increasing incidence of chronic kidney disease and improvements in healthcare infrastructure across the region.

Philippines Dialysis Market Overview

Chronic kidney disease (CKD) is a major public health burden with a prevalence rate of 9.1%-13.4%  worldwide. In Philippines, the prevalence rate stands at 35.94%, significantly higher than the global rates. Consequently, the incidence of dialysis procedures is also on the rise. Around 94% of the patients affected from end stage renal disease undergo center-based hemodialysis, whereas 4% are on peritoneal dialysis and 2% of the people undergo kidney transplantation. Hemodialysis is the most preferred treatment alternative, owing to its cost effectiveness.

Philippines dialysis market growth is driven by the increasing healthcare investments to improve the infrastructure and facilities for healthcare services across the country. Technical advancements to enhance efficiency, safety, and patient outcomes, along with a preference for portable dialysis is another significant market trend. In addition, rising partnerships between public and private authorities are expected to fuel the market value in the forecast period.

Growth in Infrastructure Improvement Activities

To facilitate affordable and technically advanced medical solutions, the Filipino government has allocated a substantial healthcare budget. This has led to significant improvements in the infrastructure, boosting the Philippines dialysis market share. In October 2023, the National  Economic and Development Authority (NEDA) Board approved the Dialysis Centre PPP project. The new project is aimed at upgrading the Renal Center Facility of the Baguio General Hospital and Medical Center (BGHMC) by setting up a fully operational dialysis center at the location. Making hemodialysis accessible to more patients has been a key agenda of the new setup.

Rising Prevalence for Home-based Solutions to Meet the Growing Philippines Dialysis Market Demand

With a surge in technical advancements, the market has been witnessing multiple innovative solutions to offer convenient and advanced care to patients. As a result, the advent of at-home portable dialyzers is a major market trend. In October 2023, Quanta Dialysis Technologies revealed that their portable at home dialysis system, titled Quanta™ Dialysis System  proved to be successful in the Home Run™ study. When compared to larger, traditional machines, the new system offered versatility and was fit to be used in multiple settings. Enabled with an intuitive user interface, it can be directly used by patients.

The prevalence for portable dialysis systems is a major market trend expected to impact the developed as well as developing countries. Consequently, the Philippines dialysis market size is poised to grow as the region expedites their efforts to improve infrastructure and bring the latest technologies for the consumers.

Increased Collaborations to Offer Early Diagnosis and Cost-Effective Services

In December 2023, the Department of the Interior and Local Government (DILG), collaborated with AstraZeneca t o offer free testing for people who might be suffering from chronic kidney disease. Launching the ACT NOW program, the 12 provincial governments aim to mitigate the rising incidence of chronic illness and educate the population with relevant information. The awareness campaign will span across major Filipino provinces including Quirino, Aurora, Cavite, Quezon, Sorsogon, Samar, Capiz, Iloilo, Cebu, Zamboanga del Norte, Agusan del Sur, and Sarangani, wherein around one million Filipinos can get free access to free Urine Albumin Creatinine Ratio (UACR) test. Early detection of CKD can help in providing appropriate treatment alternatives to the patients.

Philippines Dialysis Market Segmentation

Market Breakup by Type

• Hemodialysis
  • Conventional Hemodialysis
  • Short Daily Hemodialysis
  • Nocturnal Hemodialysis

• Peritoneal Dialysis
  • Continuous Ambulatory Peritoneal Dialysis 
  • Automated Peritoneal Dialysis

Market Breakup by Product & Services

• Equipment 
  • Dialysis Machines
  • Water Treatment Systems
  • Others

• Consumables
  • Dialyzers
  • Catheters
  • Others

• Dialysis Drugs

• Services

Market Breakup by End User

• In Center Dialysis

• Home Dialysis

Philippines Dialysis Market Regional Analysis

In June 2023, the Philippine Health Insurance Corporation  (PhilHealth) announced the expansion of their hemodialysis coverage from 90 to 156 sessions for the patients. It allows a patient to avail 3 sessions per week for a year, paying around P405,600 per year (only P2,600 per session). With economic growth and rising government emphasis on the medical sector, the region has been substantial market growth.

Manila and the national capital region as poised to lead the Philippines dialysis market share, which can be accredited to increasing initiatives aimed at boosting the infrastructure. In addition, Philippines has become a major medical tourism attraction amongst people seeking pocket-friendly healthcare services, including dialysis treatment. The country’s premium medical services, made available at an affordable price, bring plenty of foreign investments, impacting the growth of dialysis market as well.

There have been continuous efforts to enhance the quality of services on a rural level, so as to facilitate high-quality services to the marginalized communities as well.

Philippines Dialysis Market: Competitor Landscape

In April 2023, Medtronic partnered with DaVita to launch Mozarc Medical,  an independent company focused at improving kidney health and associated solutions for patients. The company seeks to improve the home dialysis scenario by allowing ease of application, clinical performance, and accessibility for the patients. Focusing on innovative and meaningful kidney health technologies, the new company aims to increase access to quality treatment globally. The establishment of the new company is a testament of rising emphasis on combating kidney associated morbidities across the globe. Several prominent companies are joining forces to expand their product portfolios.

The key features of the Philippines dialysis market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

• Fresenius SE & Co. KGaA

• Asahi Kasei Corporation

• B. Braun SE

• Baxter

• BD

• DaVita Inc.

• AngioDynamics

• Diaverum Deutschland Gmbh

• Nikkiso Co., Ltd.

• Nipro

• Hemotek

• Nepro Group Dialysis Center

• Dialife Group

• Medtronic

• NxStage Medical, Inc.

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Highlights of the Report